CH EPL (R5)
1.0.1 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: TRIOGEN Kaps 250 mg Ds 100 Stk

CH SMC - Authorized Dose Form: Capsule, hard

identifier: Medical Product Identifier/CH-01100828-0674310010000

indication:

Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.

legalStatusOfSupply: Medicinal product subject to medical or veterinary prescription (B)

additionalMonitoringIndicator: No Warning

pediatricUseIndicator: Authorised for the treatment in children

classification: trientine, NA KAS art. 12 para. 5 TPLO, Synthetic, Originator product, 07. STOFFWECHSEL, 07.99. Varia

attachedDocument:

name

productName: Triogen 250 mg, Kapseln

type: FOPH Medicinal Product Name

Usages

-CountryLanguage
*SwitzerlandGerman (Switzerland)